Radioimmunotherapy of small volume disease of colorectal cancer:: Results of a clinical phase-I/II trial

被引：0
|
作者：
Behr, TM
Liersch, T
Canelo, R
Wörmann, B
Hiddemann, W
Ringe, B
Becker, H
Becker, W
机构：
[1] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
[2] Univ Gottingen, Dept Gen Surg, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Transplantat Surg, D-3400 Gottingen, Germany
[4] Univ Gottingen, Dept Hematol Oncol, D-3400 Gottingen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [31] THE CDRH HELIX - A PHASE-I CLINICAL-TRIAL
    SHIMM, DS
    CETAS, TC
    HYNYNEN, KH
    BUECHLER, DN
    ANHALT, DP
    SYKES, HF
    CASSADY, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (02): : 110 - 113
  • [32] PHASE-I CLINICAL-TRIAL OF SODIUM CYANATE IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    HERRERAORNELAS, L
    PETRELLI, NJ
    MADAJEWICZ, S
    MITTELMAN, A
    ALLFREY, VG
    ONCOLOGY, 1985, 42 (04) : 236 - 241
  • [33] A phase I/II clinical trial of topotecan in combination with cisplatin for extensive-disease small cell lung cancer
    Seto, T.
    Ichinose, Y.
    Nishiwaki, Y.
    Kiura, K.
    Sakai, H.
    Shibuya, M.
    Takeda, K.
    Kudo, S.
    Eguchi, K.
    Watanabe, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 539 - 539
  • [34] PHASE-I TRIAL AND CLINICAL-PHARMACOLOGY OF ELSAMITRUCIN
    RABER, MN
    NEWMAN, RA
    NEWMAN, BM
    GAVER, RC
    SCHACTER, LP
    CANCER RESEARCH, 1992, 52 (06) : 1406 - 1410
  • [35] CLINICAL-EXPERIENCE WITH RHENIUM-186-LABELED MONOCLONAL-ANTIBODIES FOR RADIOIMMUNOTHERAPY - RESULTS OF PHASE-I TRIALS
    BREITZ, HB
    WEIDEN, PL
    VANDERHEYDEN, JL
    APPELBAUM, JW
    BJORN, MJ
    FER, MF
    WOLF, SB
    RATLIFF, BA
    SEILER, CA
    FOISIE, DC
    FISHER, DR
    SCHROFF, RW
    FRITZBERG, AR
    ABRAMS, PG
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (06) : 1099 - 1112
  • [36] RADIOIMMUNOTHERAPY OF LYMPHOMA WITH FRACTIONATED I-131 LYM-1 - PHASE-I/II STUDY
    DENARDO, SJ
    DENARDO, GL
    OGRADY, LF
    MACEY, DJ
    MILLS, SL
    MCGAHAN, JP
    EPSTEIN, AL
    MCGAHAN, JP
    JOURNAL OF NUCLEAR MEDICINE, 1987, 28 (06) : 1077 - 1077
  • [37] Adoptive immunotherapy with allogenous natural killer cells: Results of a phase-I/II trial in patients with metastatic kidney cancer
    Doehn, C.
    Meyer, A. J.
    Walle, L.
    Behm, A.
    Jocham, D.
    Frohn, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 265 - 265
  • [38] RECOMBINANT INTERFERON-GAMMA (IMMUNERON) - RESULTS OF A PHASE-I TRIAL IN PATIENTS WITH CANCER
    VANDERBURG, M
    EDELSTEIN, M
    GERLIS, L
    LIANG, CM
    HIRSCHI, M
    DAWSON, A
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1985, 4 (03): : 264 - 272
  • [39] PHASE-I TRIAL OF ELLIPTINIUM ACETATE IN ADVANCED CANCER
    BUZDAR, A
    YAP, HY
    GOODMAN, A
    CHOU, C
    HORTOBAGYI, G
    BLUMENSCHEIN, G
    BENJAMIN, R
    BODEY, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 182 - 182
  • [40] THE DESIGN OF PHASE-I AND PHASE-II CLINICAL-TRIALS IN CANCER - A STATISTICIANS VIEW
    GELLER, NL
    BIOMETRICS, 1984, 40 (04) : 1189 - 1190
12345